Rhine, T; Babcock, L; Zhang, N; Leach, J; Wade, S L
Are UCH-L1 and GFAP promising biomarkers for children with mild traumatic brain injury? Journal Article
In: Brain Injury, vol. 30, no. 10, pp. 1231–1238, 2016.
Abstract | Links | BibTeX | Tags: Biomarkers, Concussion, DIAGNOSIS, Paediatric
@article{Rhine2016,
title = {Are UCH-L1 and GFAP promising biomarkers for children with mild traumatic brain injury?},
author = {Rhine, T and Babcock, L and Zhang, N and Leach, J and Wade, S L},
doi = {10.1080/02699052.2016.1178396},
year = {2016},
date = {2016-01-01},
journal = {Brain Injury},
volume = {30},
number = {10},
pages = {1231--1238},
abstract = {Objectives: To compare serum biomarker levels between children with mild traumatic brain injury (mTBI) and orthopaedic injury (OI), acutely following injury. Secondarily, to explore the association between biomarker levels and symptom burden over 1 month post-injury. Methods: This was a prospective cohort study of children aged 11\textendash16 years who presented to the emergency department within 6 hours of sustaining mTBI or isolated extremity OI. Serum was drawn at the time of study enrollment and levels of ubiquitin carboxyl-terminal hydrolase L1 (UCH-L1) and glial fibrillary acid protein (GFAP) were analysed. Symptom burden was assessed by the Post-Concussion Symptom Scale (PCSS) acutely following injury and at three subsequent time points over 1 month. Results: Twenty-five children with mTBI and 20 children with OI were enrolled. The average age for the overall cohort was 13 (± 1.6) years and the majority were male and injured playing sports. GFAP levels and PCSS scores were significantly higher acutely following mTBI vs OI (p \< 0.01). There was not a significant group difference in UCH-L1 levels. Neither GFAP nor UCH-L1 were predictive of PCSS scores over the 1month post-injury. Conclusions: GFAP may be a promising diagnostic tool for children with mTBI. Additional approaches are needed to predict symptom severity and persistence. © 2016 Taylor \& Francis Group, LLC.},
keywords = {Biomarkers, Concussion, DIAGNOSIS, Paediatric},
pubstate = {published},
tppubtype = {article}
}
Rhine, T; Babcock, L; Zhang, N; Leach, J; Wade, S L
Are UCH-L1 and GFAP promising biomarkers for children with mild traumatic brain injury? Journal Article
In: Brain Injury, vol. 30, no. 10, pp. 1231–1238, 2016.
@article{Rhine2016,
title = {Are UCH-L1 and GFAP promising biomarkers for children with mild traumatic brain injury?},
author = {Rhine, T and Babcock, L and Zhang, N and Leach, J and Wade, S L},
doi = {10.1080/02699052.2016.1178396},
year = {2016},
date = {2016-01-01},
journal = {Brain Injury},
volume = {30},
number = {10},
pages = {1231--1238},
abstract = {Objectives: To compare serum biomarker levels between children with mild traumatic brain injury (mTBI) and orthopaedic injury (OI), acutely following injury. Secondarily, to explore the association between biomarker levels and symptom burden over 1 month post-injury. Methods: This was a prospective cohort study of children aged 11\textendash16 years who presented to the emergency department within 6 hours of sustaining mTBI or isolated extremity OI. Serum was drawn at the time of study enrollment and levels of ubiquitin carboxyl-terminal hydrolase L1 (UCH-L1) and glial fibrillary acid protein (GFAP) were analysed. Symptom burden was assessed by the Post-Concussion Symptom Scale (PCSS) acutely following injury and at three subsequent time points over 1 month. Results: Twenty-five children with mTBI and 20 children with OI were enrolled. The average age for the overall cohort was 13 (± 1.6) years and the majority were male and injured playing sports. GFAP levels and PCSS scores were significantly higher acutely following mTBI vs OI (p \< 0.01). There was not a significant group difference in UCH-L1 levels. Neither GFAP nor UCH-L1 were predictive of PCSS scores over the 1month post-injury. Conclusions: GFAP may be a promising diagnostic tool for children with mTBI. Additional approaches are needed to predict symptom severity and persistence. © 2016 Taylor \& Francis Group, LLC.},
keywords = {},
pubstate = {published},
tppubtype = {article}
}
Rhine, T; Babcock, L; Zhang, N; Leach, J; Wade, S L
Are UCH-L1 and GFAP promising biomarkers for children with mild traumatic brain injury? Journal Article
In: Brain Injury, vol. 30, no. 10, pp. 1231–1238, 2016.
Abstract | Links | BibTeX | Tags: Biomarkers, Concussion, DIAGNOSIS, Paediatric
@article{Rhine2016,
title = {Are UCH-L1 and GFAP promising biomarkers for children with mild traumatic brain injury?},
author = {Rhine, T and Babcock, L and Zhang, N and Leach, J and Wade, S L},
doi = {10.1080/02699052.2016.1178396},
year = {2016},
date = {2016-01-01},
journal = {Brain Injury},
volume = {30},
number = {10},
pages = {1231--1238},
abstract = {Objectives: To compare serum biomarker levels between children with mild traumatic brain injury (mTBI) and orthopaedic injury (OI), acutely following injury. Secondarily, to explore the association between biomarker levels and symptom burden over 1 month post-injury. Methods: This was a prospective cohort study of children aged 11\textendash16 years who presented to the emergency department within 6 hours of sustaining mTBI or isolated extremity OI. Serum was drawn at the time of study enrollment and levels of ubiquitin carboxyl-terminal hydrolase L1 (UCH-L1) and glial fibrillary acid protein (GFAP) were analysed. Symptom burden was assessed by the Post-Concussion Symptom Scale (PCSS) acutely following injury and at three subsequent time points over 1 month. Results: Twenty-five children with mTBI and 20 children with OI were enrolled. The average age for the overall cohort was 13 (± 1.6) years and the majority were male and injured playing sports. GFAP levels and PCSS scores were significantly higher acutely following mTBI vs OI (p \< 0.01). There was not a significant group difference in UCH-L1 levels. Neither GFAP nor UCH-L1 were predictive of PCSS scores over the 1month post-injury. Conclusions: GFAP may be a promising diagnostic tool for children with mTBI. Additional approaches are needed to predict symptom severity and persistence. © 2016 Taylor \& Francis Group, LLC.},
keywords = {Biomarkers, Concussion, DIAGNOSIS, Paediatric},
pubstate = {published},
tppubtype = {article}
}